Clinical Trials Browser

Phase 1 × calcipotriene × Tumor-Agnostic × Clear all

NCT03370406 2025-06-15

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

Phase 1 Recruiting

Carcinoma, Carcinoma, Squamous Cell